» Articles » PMID: 36012258

DNA Methyltransferases: From Evolution to Clinical Applications

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Aug 26
PMID 36012258
Authors
Affiliations
Soon will be listed here.
Abstract

DNA methylation is an epigenetic mark that living beings have used in different environments. The MTases family catalyzes DNA methylation. This process is conserved from archaea to eukaryotes, from fertilization to every stage of development, and from the early stages of cancer to metastasis. The family of DNMTs has been classified into DNMT1, DNMT2, and DNMT3. Each DNMT has been duplicated or deleted, having consequences on DNMT structure and cellular function, resulting in a conserved evolutionary reaction of DNA methylation. DNMTs are conserved in the five kingdoms of life: bacteria, protists, fungi, plants, and animals. The importance of DNMTs in whether methylate or not has a historical adaptation that in mammals has been discovered in complex regulatory mechanisms to develop another padlock to genomic insurance stability. The regulatory mechanisms that control DNMTs expression are involved in a diversity of cell phenotypes and are associated with pathologies transcription deregulation. This work focused on DNA methyltransferases, their biology, functions, and new inhibitory mechanisms reported. We also discuss different approaches to inhibit DNMTs, the use of non-coding RNAs and nucleoside chemical compounds in recent studies, and their importance in biological, clinical, and industry research.

Citing Articles

Embryo vitrification impacts learning and spatial memory by altering the imprinting genes expression level in the mouse offspring' hippocampus.

Hosseini S, Hosseini S, Aligholi H, Salehi M Sci Rep. 2025; 15(1):5419.

PMID: 39948414 PMC: 11825692. DOI: 10.1038/s41598-025-89857-6.


Epigenetics in Skin Homeostasis and Ageing.

Dermitzakis I, Kyriakoudi S, Chatzianagnosti S, Chatzi D, Vakirlis E, Meditskou S Epigenomes. 2025; 9(1.

PMID: 39846570 PMC: 11755608. DOI: 10.3390/epigenomes9010003.


Down-regulation of SLC14A1 in prostate cancer activates CDK1/CCNB1 and mTOR pathways and promotes tumor progression.

Ma J, Xue K, Jiang Y, Wang X, He D, Guo P Sci Rep. 2024; 14(1):14914.

PMID: 38942821 PMC: 11213927. DOI: 10.1038/s41598-024-66020-1.


Systematic Characterization of DNA Methyltransferases Family in Tumor Progression and Antitumor Immunity.

Huang F, Wu X, Du Q, Lin J, Ma W, Liu J Technol Cancer Res Treat. 2024; 23:15330338241260658.

PMID: 38847740 PMC: 11162131. DOI: 10.1177/15330338241260658.


Research progress and applications of epigenetic biomarkers in cancer.

Gao J, Shi W, Wang J, Guan C, Dong Q, Sheng J Front Pharmacol. 2024; 15:1308309.

PMID: 38681199 PMC: 11048075. DOI: 10.3389/fphar.2024.1308309.


References
1.
Li E, Zhang Y . DNA methylation in mammals. Cold Spring Harb Perspect Biol. 2014; 6(5):a019133. PMC: 3996472. DOI: 10.1101/cshperspect.a019133. View

2.
Robertson K, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales F . The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res. 1999; 27(11):2291-8. PMC: 148793. DOI: 10.1093/nar/27.11.2291. View

3.
Brambert P, Kelpsch D, Hameed R, Desai C, Calafiore G, Godley L . DNMT3B7 expression promotes tumor progression to a more aggressive phenotype in breast cancer cells. PLoS One. 2015; 10(1):e0117310. PMC: 4301645. DOI: 10.1371/journal.pone.0117310. View

4.
Bahar Halpern K, Vana T, Walker M . Paradoxical role of DNA methylation in activation of FoxA2 gene expression during endoderm development. J Biol Chem. 2014; 289(34):23882-92. PMC: 4156079. DOI: 10.1074/jbc.M114.573469. View

5.
Smith T, Collins T, McGowan R . Expression of the dnmt3 genes in zebrafish development: similarity to Dnmt3a and Dnmt3b. Dev Genes Evol. 2011; 220(11-12):347-53. DOI: 10.1007/s00427-010-0347-z. View